Glenmark gets FDA’s blessing for generic Vesicare

Press enter to search
Close search
Open Menu

Glenmark gets FDA’s blessing for generic Vesicare

By Sandra Levy - 05/21/2019
Glenmark Pharmaceuticals has received the green light from the Food and Drug Administration for solifenacin succinate tablets, in 5 mg and 10 mg dosages strengths.

Solifenacin succinate tablets are the generic of Astellas Pharma’s Vesicare tablets, 5 mg and 10 mg.

The product had a market value of roughly $942.7 million for the 12 month period ending March 2019, according to IQVIA.

RELATED TOPICS